These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 22301383)
1. Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model. Tsilingiri K; Barbosa T; Penna G; Caprioli F; Sonzogni A; Viale G; Rescigno M Gut; 2012 Jul; 61(7):1007-15. PubMed ID: 22301383 [TBL] [Abstract][Full Text] [Related]
2. Should probiotics be tested on ex vivo organ culture models? Tsilingiri K; Rescigno M Gut Microbes; 2012; 3(5):442-8. PubMed ID: 22713266 [TBL] [Abstract][Full Text] [Related]
3. A major advance in ex vivo intestinal organ culture. Wildenberg ME; van den Brink GR Gut; 2012 Jul; 61(7):961-2. PubMed ID: 22315470 [No Abstract] [Full Text] [Related]
4. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations. Drouault-Holowacz S; Foligné B; Dennin V; Goudercourt D; Terpend K; Burckel A; Pot B Clin Nutr; 2006 Dec; 25(6):994-1003. PubMed ID: 16698150 [TBL] [Abstract][Full Text] [Related]
5. Development of an Ex Vivo Organ Culture Technique to Evaluate Probiotic Utilization in IBD. Pagnini C; Martorelli M; Lanini C; Delle Fave G J Clin Gastroenterol; 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015():S179-S182. PubMed ID: 27741170 [TBL] [Abstract][Full Text] [Related]
6. Probiotics: use in allergic disorders: a Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report. Isolauri E; Salminen S; J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S91-6. PubMed ID: 18542035 [TBL] [Abstract][Full Text] [Related]
7. Probiotic-induced apoptosis and its potential relevance to mucosal inflammation of gastrointestinal tract. Daniluk U; Alifier M; Kaczmarski M Adv Med Sci; 2012; 57(2):175-82. PubMed ID: 22968339 [TBL] [Abstract][Full Text] [Related]
8. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Dunne C; Murphy L; Flynn S; O'Mahony L; O'Halloran S; Feeney M; Morrissey D; Thornton G; Fitzgerald G; Daly C; Kiely B; Quigley EM; O'Sullivan GC; Shanahan F; Collins JK Antonie Van Leeuwenhoek; 1999; 76(1-4):279-92. PubMed ID: 10532384 [TBL] [Abstract][Full Text] [Related]
15. What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease? Cary VA; Boullata J J Clin Nurs; 2010 Apr; 19(7-8):904-16. PubMed ID: 20492035 [TBL] [Abstract][Full Text] [Related]
16. Effects of exopolysaccharide-producing probiotic strains on experimental colitis in rats. Sengül N; Aslím B; Uçar G; Yücel N; Işik S; Bozkurt H; Sakaoğullari Z; Atalay F Dis Colon Rectum; 2006 Feb; 49(2):250-8. PubMed ID: 16362802 [TBL] [Abstract][Full Text] [Related]
17. Role of microecology in chronic inflammatory bowel diseases. Guarner F; Casellas F; Borruel N; Antolín M; Videla S; Vilaseca J; Malagelada JR Eur J Clin Nutr; 2002 Dec; 56 Suppl 4():S34-8. PubMed ID: 12556945 [TBL] [Abstract][Full Text] [Related]
18. Rationale for probiotic treatment strategies in inflammatory bowel disease. Schultz M; Lindström AL Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):337-55. PubMed ID: 19072384 [TBL] [Abstract][Full Text] [Related]
19. Microecology as a target for therapeutic intervention in inflammatory bowel disease. Guarner F IDrugs; 2003 Sep; 6(9):868-73. PubMed ID: 12964066 [TBL] [Abstract][Full Text] [Related]
20. Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease. Gassull MA Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():90-5. PubMed ID: 16961752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]